Novel Compound Protects Against Infection by Virus that Causes COVID-19, Preliminary Studies Show

• Stapled lipopeptides successfully deter infection by the SARS-CoV-2 virus and reduce the severity of COVID-19 in tests with hamsters

Related Keywords

Dana Farber Cancer Institute ,Massachusetts ,United States ,Boston ,Boston University ,Cambridge ,Cambridgeshire ,United Kingdom ,Aaron Moss ,Loren Walensky ,Richard Bowen ,Robert Davey ,Microbiology At Boston University ,Nature Communications ,National Institutes Of Health ,Massachusetts Consortium On Pathogen Readiness ,Blood Disorders Center ,Colorado State University ,Boston University National Emerging Infectious Diseases Laboratories ,Principal Investigator ,Linde Program ,Cancer Chemical Biology ,Boston Children ,Blood Disorders ,Gregory Bird ,Red Queen Therapeutics ,Queen Therapeutics ,Red Queen ,Massachusetts Consortium ,Pathogen Readiness ,National Institutes ,Pre Clinical Services Program ,National Institute ,Infectious Diseases ,Colorado State ,Newswise ,Covid 19 ,All Journal News ,Clinical Trials ,Icrobiome ,Coronavirus ,